- Published at
- by biznews.com
mixed
mixed
Optimi Health granted license to export psychedelics to Australia
Canada has licensed Optimi Health to export psilocybin and MDMA to Australia, marking a significant step in the medical psychedelics market.
News for Awakn Life Sciences Corp. (AWKNF)
- Published at
- by financialpost.com
mixedmixed- Published at
- by marketscreener.com
positivepositiveAwakn Life Sciences Corp. (AWKN)
Effective immediately, Awakn Life Sciences Corp. will be reinstated for trading. The Company has rectified the situation that gave rise to the suspension. ...- Published at
- by marketscreener.com
neutralneutralAwakn Life Sciences Discusses Filing of Financial Statements
Awakn Life Sciences Corp. , a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder , announces that, it...- Published at
- by marketscreener.com
positivepositiveCSE Bulletin: New Listing - Awakn Life Sciences Corp. (AWKN) -February 12, 2024 at 01:55 pm EST
The common shares of Awakn Life Sciences Corp. have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date. ...- Published at
- by marketscreener.com
positivepositiveAwakn Life Sciences Announces Listing on the Canadian Securities Exchange
Awakn Life Sciences Corp. , a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder , is pleased to announce...- Published at
- by investorideas.com
positivepositiveCSE Biotech Listing - Awakn Life Sciences Corp. (CSE: AWKN)
February 9, 2024 (Investorideas.com Newswire) The common shares of Awakn Life Sciences Corp. have been approved for listing on the CSE. Listing and disclosure ...- Published at
- by investorideas.com
positivepositiveBiotech Stock Awakn Life Sciences (CBOE: AWKN) (OTCQB: AWKNF) Completes Successful Investigative Study
Toronto, Ontario - January 24, 2024 (Newsfile Corp.) (Investorideas.com Newswire) Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a ...- Published at
- by marketscreener.com
positivepositiveAwakn Life Sciences Completes Successful Investigative Study to Establish Dissociative Effect of a Proprietary Sublingual S-Ketamine Oral Thin Film Formulation in Harmful Drinkers
Awakn Life Sciences Corp. , a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder , is pleased to announce...- Published at
- by benzinga.com
mixedmixedPsyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More - Awakn Life Sciences (OTC:AWKNF), ATAI Life Sciences (NASDAQ:ATAI)
President Biden Approves Psychedelics Clinical Trials For Active Military Members President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also contains a mandate to fund clinical trials with psychedelics for active service members.- Published at
- by marketscreener.com
positivepositiveAwakn Life Sciences Provides Corporate Update
Awakn Life Sciences Corp. , a clinical-stage biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder , shares a corporate update on recent...- Published at
- by benzinga.com
mixedmixedPsyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More - Awakn Life Sciences (OTC:AWKNF), Incannex Healthcare (NASDAQ:IXHL)
Oregon Pioneers Legal Psilocybin Therapy, But This Type Of License Has Yet To Be Issued- Published at
- by benzinga.com
mixedmixedPsyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project - Awakn Life Sciences (OTC:AWKNF), Braxia Scientific (OTC:BRAXF)
Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and further guidance for pre-clinical research and studies with young participants.- Published at
- by globenewswire.com
mixedmixed- Published at
- by benzinga.com
mixedmixed- Published at
- by benzinga.com
mixedmixedPsyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS - ATA (ATAI), Cybin Inc. Common Shares (CYBN), FIELD TRIP HEALTH CM (FTRP)
New Awakn Study Shows Ketamine Has Potential To Treat Alcoholism Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB:- Published at
- by benzinga.com
mixedmixedThere Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are - ATA (ATAI), COMP SERVICES (CMPS)
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...